Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

[Familial hypercholesterolemia].

Windler E, Beil FU, Altenburg C, Rinninger F.

Dtsch Med Wochenschr. 2012 Nov;137(46):2375-9. doi: 10.1055/s-0032-1327259. Epub 2012 Nov 6. German.

PMID:
23132157
2.

The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.

Jensen HK.

Dan Med Bull. 2002 Nov;49(4):318-45. Review.

PMID:
12553167
3.

Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia.

van Aalst-Cohen ES, Jansen AC, de Jongh S, de Sauvage Nolting PR, Kastelein JJ.

Semin Vasc Med. 2004 Feb;4(1):31-41. Review.

PMID:
15199431
4.

Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children.

Wiegman A, Rodenburg J, de Jongh S, Defesche JC, Bakker HD, Kastelein JJ, Sijbrands EJ.

Circulation. 2003 Mar 25;107(11):1473-8.

5.

Familial hypercholesterolemia: a challenge of diagnosis and therapy.

Sibley C, Stone NJ.

Cleve Clin J Med. 2006 Jan;73(1):57-64. Review.

PMID:
16444917
6.

Homozygous familial hypercholesterolemia and its management.

Marais AD, Firth JC, Blom DJ.

Semin Vasc Med. 2004 Feb;4(1):43-50. Review.

PMID:
15199432
7.

Universal screening of cholesterol in children.

Kwiterovich PO, Gidding SS.

Clin Cardiol. 2012 Nov;35(11):662-4. doi: 10.1002/clc.22050. Epub 2012 Aug 28.

8.

Genetic and metabolic factors predicting risk of cardiovascular disease in familial hypercholesterolemia.

Smilde TJ, van Wissen S, Wollersheim H, Kastelein JJ, Stalenhoef AF.

Neth J Med. 2001 Oct;59(4):184-95. Review.

PMID:
11578794
9.

Familial hypercholesterolemia: genetic predisposition to atherosclerosis.

Engler MB.

Medsurg Nurs. 2004 Aug;13(4):253-7.

PMID:
15384479
10.
11.

Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes.

Alonso R, Mata P, Zambón D, Mata N, Fuentes-Jiménez F.

Expert Rev Cardiovasc Ther. 2013 Mar;11(3):327-42. doi: 10.1586/erc.13.7. Review.

PMID:
23469913
12.

Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.

Lee WP, Datta BN, Ong BB, Rees A, Halcox J.

Am J Cardiovasc Drugs. 2011 Dec 1;11(6):363-70. doi: 10.2165/11594970-000000000-00000. Review.

PMID:
22149315
13.

DNA testing for familial hypercholesterolemia: improving disease recognition and patient care.

Vergopoulos A, Knoblauch H, Schuster H.

Am J Pharmacogenomics. 2002;2(4):253-62. Review.

PMID:
12421096
14.
15.

Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.

van der Graaf A, Hutten BA, Kastelein JJ, Vissers MN.

Expert Rev Cardiovasc Ther. 2006 May;4(3):345-51. Review.

PMID:
16716095
16.

[Diagnosis and effective therapy with plasmapheresis in a patient with homozygous familial hypercholesterolemia].

Widhalm K, Kleinberger G, Strobl W, Pachinger O, Kaliman J.

Helv Paediatr Acta. 1984 May;39(2):153-60. German.

PMID:
6543838
17.

Cholesterol and family history: when genetics matters.

Vengoechea J, McKelvey KD.

J Ark Med Soc. 2015 Feb;111(9):184-6.

PMID:
25993767
18.

Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia.

Zwiener RJ, Uauy R, Petruska ML, Huet BA.

J Pediatr. 1995 May;126(5 Pt 1):728-35.

PMID:
7751996
19.

Long-term compliance with lipid-lowering medication after genetic screening for familial hypercholesterolemia.

Umans-Eckenhausen MA, Defesche JC, van Dam MJ, Kastelein JJ.

Arch Intern Med. 2003 Jan 13;163(1):65-8.

PMID:
12523918
20.

Heterozygous familial hypercholesterolaemia in childhood: cardiovascular risk prevention.

van der Graaf A, Kastelein JJ, Wiegman A.

J Inherit Metab Dis. 2009 Dec;32(6):699-705. doi: 10.1007/s10545-009-1165-1. Epub 2009 Oct 31. Review.

PMID:
19898954

Supplemental Content

Support Center